2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Por um escritor misterioso
Last updated 01 junho 2024
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Secondary diabetes mellitus in acromegaly
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
PDF) A Risk-Benefit Assessment of Octreotide in the Treatment of Acromegaly
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Trends in insulin-like growth factor-1 levels after bariatric surgery: a systematic review and meta-analysis
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Chapters Archive - Page 11 of 44 - Endotext
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Acromegaly - ScienceDirect
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
(PDF) How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
Acromegaly - ScienceDirect
2010 versus the 2000 consensus criteria in patients with normalised  insulin‐like growth factor 1 after transsphenoidal surgery has high  predictive values for long‐term recurrence‐free survival in acromegaly -  Shen - 2021
A) sFRP-4 protein expression in pituitary adenoma cell lines (GH3) and

© 2014-2024 khosatthep.net. All rights reserved.